SCOPUS 정보 검색 플랫폼

Blood

Volumn 113, Issue 24, 2009, Pages 6044-6045

Notch targeting 2.0

(1) Aster, Jon C a

a BRIGHAM AND WOMEN S HOSPITAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; MUTANT PROTEIN; NOTCH1 RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; DRUG TARGETING; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; T CELL LEUKEMIA;

EID: 70449498842 PISSN: 00064971 EISSN: 15280020 Source Type: Journal
DOI: 10.1182/blood-2009-03-212829 Document Type: Note

Times cited : (2)

References (8)

1
- 41749118698
- Notch signaling in leukemia
- Aster JC, Pear WS, Blacklow SC. Notch signaling in leukemia. Annu Rev Pathol. 2008;3:587-613.
- (2008) Annu Rev Pathol. , vol.3 , pp. 587-613
- Aster, J.C.¹ Pear, W.S.² Blacklow, S.C.³

2
- 34548592412
- A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias
- Deangelo DJ, Stone RM, Silverman LB, et al. A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias. J Clin Oncol. 2006;24:6585.
- (2006) J Clin Oncol. , vol.24 , pp. 6585
- Deangelo, D.J.¹ Stone, R.M.² Silverman, L.B.³

3
- 58149336788
- Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
- Real PJ, Tosello V, Palomero T, et al. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med. 2009;15:50-58.
- (2009) Nat Med. , vol.15 , pp. 50-58
- Real, P.J.¹ Tosello, V.² Palomero, T.³

4
- 0032442040
- Correlating notch signaling with thymocyte maturation
- Deftos ML, He YW, Ojala EW, Bevan MJ. Correlating notch signaling with thymocyte maturation. Immunity. 1998;9:777-786.
- (1998) Immunity , vol.9 , pp. 777-786
- Deftos, M.L.¹ He, Y.W.² Ojala, E.W.³ Bevan, M.J.⁴

5
- 67650389196
- Targeting the Notch1 and mTOR pathways in a mouse T-ALL model
- Cullion K, Draheim KM, Hermance N, et al. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood. 2009;113:6172-6181.
- (2009) Blood , vol.113 , pp. 6172-6181
- Cullion, K.¹ Draheim, K.M.² Hermance, N.³

6
- 34347369749
- Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia
- Chan S, Weng AP, Tibshirani R, et al. Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood. 2007;100:278-286.
- (2007) Blood , vol.100 , pp. 278-286
- Chan, S.¹ Weng, A.P.² Tibshirani, R.³

7
- 34948908663
- Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
- DOI 10.1038/nm1636, PII NM1636
- Palomero T, Sulis ML, Cortina M, et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med. 2007;13:1203-1210. (Pubitemid 47530629)
- (2007) Nature Medicine , vol.13 , Issue.10 , pp. 1203-1210
- Palomero, T.¹ Sulis, M.L.² Cortina, M.³ Real, P.J.⁴ Barnes, K.⁵ Ciofani, M.⁶ Caparros, E.⁷ Buteau, J.⁸ Brown, K.⁹ Perkins, S.L.¹⁰ Bhagat, G.¹¹ Agarwal, A.M.¹² Basso, G.¹³ Castillo, M.¹⁴ Nagase, S.¹⁵ Cordon-Cardo, C.¹⁶ Parsons, R.¹⁷ Zuniga-Pflucker, J.C.¹⁸ Dominguez, M.¹⁹ Ferrando, A.A.²⁰ more..

8
- 33749443714
- Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance
- DOI 10.1016/j.ccr.2006.09.006, PII S1535610806002832
- Wei G, Twomey D, Lamb J, et al. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell. 2006;10:331-342. (Pubitemid 44512194)
- (2006) Cancer Cell , vol.10 , Issue.4 , pp. 331-342
- Wei, G.¹ Twomey, D.² Lamb, J.³ Schlis, K.⁴ Agarwal, J.⁵ Stam, R.W.⁶ Opferman, J.T.⁷ Sallan, S.E.⁸ Den Boer, M.L.⁹ Pieters, R.¹⁰ Golub, T.R.¹¹ Armstrong, S.A.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.